Fischer K - Search Results

1

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations.

Hermans C, De Moerloose P, Fischer K, Holstein K, Klamroth R, Lambert T, Lavigne-Lissalde G, Perez R, Richards M, Dolan G; European Haemophilia Therapy Standardisation Board. Hermans C, et al. Among authors: fischer k. Haemophilia. 2011 May;17(3):383-92. doi: 10.1111/j.1365-2516.2010.02449.x. Epub 2011 Feb 15. Haemophilia. 2011. PMID: 21323794 Review.

2

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2001 Sep;7(5):446-52. doi: 10.1046/j.1365-2516.2001.00545.x. Haemophilia. 2001. PMID: 11554930

3

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

Fischer K, Van Der Bom JG, Prejs R, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, Van Den Berg HM. Fischer K, et al. Haemophilia. 2001 Nov;7(6):544-50. doi: 10.1046/j.1365-2516.2001.00560.x. Haemophilia. 2001. PMID: 11851751

4

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

van den Berg HM, Fischer K, van der Bom JG, Roosendaal G, Mauser-Bunschoten EP. van den Berg HM, et al. Among authors: fischer k. Haemophilia. 2002 Mar;8 Suppl 2:43-6. doi: 10.1046/j.1351-8216.2001.00120.x. Haemophilia. 2002. PMID: 11966853

5

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

Fischer K, van der Bom JG, Molho P, Negrier C, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2002 Nov;8(6):745-52. doi: 10.1046/j.1365-2516.2002.00695.x. Haemophilia. 2002. PMID: 12410642

6

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

Fischer K, Astermark J, van der Bom JG, Ljung R, Berntorp E, Grobbee DE, van den Berg HM. Fischer K, et al. Haemophilia. 2002 Nov;8(6):753-60. doi: 10.1046/j.1365-2516.2002.00694.x. Haemophilia. 2002. PMID: 12410643

7

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Among authors: fischer k. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030

8

Comparing outcomes of different treatment regimens for severe haemophilia.

van den Berg HM, Fischer K, van der Bom JG. van den Berg HM, et al. Among authors: fischer k. Haemophilia. 2003 May;9 Suppl 1:27-31; discussion 31. doi: 10.1046/j.1365-2516.9.s1.10.x. Haemophilia. 2003. PMID: 12709034

9

Health-related quality of life as outcome parameter in haemophilia treatment.

Fischer K, van der Bom JG, van den Berg HM. Fischer K, et al. Haemophilia. 2003 May;9 Suppl 1:75-81; discussion 82. doi: 10.1046/j.1365-2516.9.s1.13.x. Haemophilia. 2003. PMID: 12709041 Review.

10

Prophylaxis for severe haemophilia: clinical and economical issues.

Fischer K, Van Den Berg M. Fischer K, et al. Haemophilia. 2003 Jul;9(4):376-81. doi: 10.1046/j.1365-2516.2003.00764.x. Haemophilia. 2003. PMID: 12828671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,847 results

Search Page

Filters